Connect your AI

Agilon Health AGL Proceeds From Repurchase Of Equity

Proceeds From Repurchase Of Equity at other companies

InnovAge Holdings, Inc.INNV

$0+100%

Other financials

Income statement

Revenue$1.4B-7.3%

Operating income$4.0M+118%

Net income$48.9M+304%

EPS (diluted)$2.94+303%

Balance sheet

Cash & equivalents$211.6M+52.6%

Total debt$33.4M-20.5%

Total equity$181.4M-63.7%

Total assets$1.5B-22.1%

Cash flow

Operating cash flow$23.7M+174%

CapEx$3.1M-19.4%

Free cash flow$20.6M+158%

Valuation

Market cap$1.78B-92.6%

Enterprise value$1.61B-103%

P/S0.3×-3.8×

Profitability

Operating margin-7.5%+6.5pp

Net margin-6.1%+6.3pp

FCF margin-1.1%—

Returns & leverage

Return on equity-104%-291pp

Debt / equity0.2×+0.1×

Current ratio1×-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromRepurchaseOfEquity.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's proceeds from repurchase of equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Agilon Health's proceeds from repurchase of equity?: Agilon Health (AGL) reported proceeds from repurchase of equity of -$35K in Q1 2026.